• Home
  •  / Ra Medical Systems

Ra Medical Systems

OverviewSuggest Edit

Ra Medical Systems is a company that develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. It offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company also provides Pharos, an excimer laser device that emits concentrated ultraviolet light used in the treatment of dermatological skin disorders.

TypePublic
Founded2002
HQCarlsbad, CA, USMap
Websiteramed.com

Recent NewsAll News

Latest Updates

Employees (est.) (Mar 2020)86(+9%)
Revenue (FY, 2020)$4.4 M(-38%)
Share Price (May 2021)$3.7(-4%)
Cybersecurity ratingAMore

Key People/Management at Ra Medical Systems

Martin Colombatto

Martin Colombatto

Chairman of the Board
Will McGuire

Will McGuire

Chief Executive Officer and Director
Jeffrey Kraws

Jeffrey Kraws

President
Andrew Jackson

Andrew Jackson

CFO
Dan Horwood

Dan Horwood

General Counsel and Secretary
Mark E. Saad

Mark E. Saad

Director
Show more

Ra Medical Systems Office Locations

Ra Medical Systems has an office in Carlsbad
Carlsbad, CA, US (HQ)
2070 Las Palmas Dr
Show all (1)

Ra Medical Systems Financials and Metrics

Ra Medical Systems Revenue

Embed Graph
View revenue for all periods
Ra Medical Systems's revenue was reported to be $4.41 m in FY, 2020
USD

Revenue (FY, 2020)

4.4m

Gross profit (FY, 2020)

(1.1m)

Gross profit margin (FY, 2020), %

(24.4%)

Net income (FY, 2020)

(36.0m)

EBIT (FY, 2020)

(36.1m)

Market capitalization (3-May-2021)

12.1m

Closing stock price (3-May-2021)

3.7

Cash (31-Dec-2020)

23.9m

EV

(9.1m)
Ra Medical Systems's current market capitalization is $12.1 m.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

6.0m5.9m6.3m7.2m4.4m

Revenue growth, %

(2%)

Cost of goods sold

3.1m4.2m4.2m8.9m5.5m

Gross profit

2.8m1.7m2.1m(1.7m)(1.1m)
Quarterly
USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

2.1m1.7m2.2m1.9m1.4m900.0k914.0k

Cost of goods sold

1.3m1.9m2.7m2.4m1.6m1.2m1.4m

Gross profit

784.0k(194.0k)(580.0k)(517.0k)(210.0k)(267.0k)(504.0k)

Gross profit Margin, %

38%(11%)(27%)(27%)(15%)(30%)(55%)
show all
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

3.9m8.2m64.3m14.6m23.9m

Accounts Receivable

393.0k517.0k1.3m786.0k238.0k

Prepaid Expenses

124.0k92.0k1.5m1.9m1.3m

Inventories

870.0k1.2m2.1m2.8m2.2m
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

9.8m4.9m55.1m11.8m14.5m18.4m29.4m33.6m

Accounts Receivable

761.0k1.3m1.3m1.5m1.3m684.0k474.0k475.0k

Prepaid Expenses

267.0k237.0k1.8m1.3m1.1m1.8m1.2m466.0k

Inventories

1.3m1.3m2.2m2.3m2.6m2.8m2.7m2.6m
show all
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(4.2m)(17.8m)(30.8m)(57.0m)(36.0m)

Depreciation and Amortization

95.0k218.0k624.0k1.4m4.4m

Inventories

(181.0k)(644.0k)(3.9m)(2.2m)352.0k

Accounts Payable

124.0k(47.0k)699.0k407.0k(961.0k)
Quarterly
USDQ2, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(12.9m)(11.1m)(15.9m)(14.7m)(29.8m)(47.2m)(7.7m)(17.8m)(25.6m)

Depreciation and Amortization

86.0k231.0k388.0k303.0k669.0k1.0m493.0k1.0m1.6m

Inventories

(737.0k)(1.1m)(1.7m)(843.0k)(1.5m)(1.8m)(98.0k)33.0k78.0k

Accounts Payable

218.0k76.0k695.0k286.0k390.0k(121.0k)(176.0k)107.0k(633.0k)
show all
USDFY, 2016

Financial Leverage

-15.4 x
Show all financial metrics

Ra Medical Systems Operating Metrics

Ra Medical Systems's Patients was reported to be 64 in Q2, 2018.
Q2, 2018

Patients

64
Show all operating metrics

Ra Medical Systems Revenue Breakdown

Embed Graph

Ra Medical Systems revenue breakdown by business segment: 95.6% from Dermatology and 4.4% from Other

Ra Medical Systems revenue breakdown by geographic segment: 89.8% from United States and 10.2% from All other countries

Ra Medical Systems Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

Learn more about our premium products
SecurityScorecard logo

Ra Medical Systems Online and Social Media Presence

Ra Medical Systems's Trends

Embed Graph

Ra Medical Systems News and Updates

October 04, 2019

WeissLaw LLP: Ra Medical Systems, Inc. is the Subject of a Legal Investigation

NEW YORK, Oct. 4, 2019 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, Los Angeles and Atlanta, announces an investigation of Ra Medical Systems, Inc. (NYSE: RMED) ("RMED," or the "Company"). If you own RMED shares and wish...
July 12, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ra Medical Systems, Inc. To Contact The Firm

NEW YORK, July 12, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. (Ra Medical or the "Company") (NYSE:RMED) of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class...
June 26, 2019

RM LAW Announces Class Action Lawsuit Against Ra Medical Systems, Inc.

BERWYN, Pa., June 26, 2019 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) common stock pursuant and/or traceable to the Company's...
June 07, 2019

RA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ra Medical Systems, Inc. To Contact The Firm

NEW YORK, June 7, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE:RMED). If you invested in Ra Medical stock or options and would like to discuss...
June 05, 2019

Former California Deputy Attorney General and Special Counsel with Johnson Fistel Launches Investigation into Ra Medical Systems, Inc. (RMED)

SAN DIEGO, June 5, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq., is investigating potential claims against Ra Medical Systems, Inc. ("Ra Medical") (NYSE:...

Ra Medical Systems Blogs

April 20, 2021

Ra Medical Systems Provides Enrollment Update for its Pivotal Atherectomy Clinical Trial

42 total subjects enrolled as of April 19, 2021 12 subjects enrolled since mid-March CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, an…
April 19, 2021

Ra Medical Systems to Report First Quarter 2021 Financial Results on May 11, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report first quarter 2021 financial results after market close on Tuesday, May 11, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific…
March 16, 2021

Ra Medical Systems Reports 2020 Fourth Quarter and Full Year Financial Results

 Conference call begins at 4:30 p.m. Eastern time today CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for th…
March 11, 2021

Ra Medical Systems to Participate in Upcoming Virtual Investment Conferences

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in two upcoming virtual investment conferences:…
March 09, 2021

Ra Medical Systems to Report 2020 Fourth Quarter and Full Year Financial Results on March 16, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2020 fourth quarter and full year financial results and provide a business update after market close on Tuesday, March 16, 2021. Ra Medical management will hold an investment community confere…
March 02, 2021

Ra Medical Systems to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present a company overview and hold virtual meetings with i…
Show more

 Ra Medical Systems Frequently Asked Questions

  • When was Ra Medical Systems founded?

    Ra Medical Systems was founded in 2002.

  • Who are Ra Medical Systems key executives?

    Ra Medical Systems's key executives are Martin Colombatto, Will McGuire and Jeffrey Kraws.

  • How many employees does Ra Medical Systems have?

    Ra Medical Systems has 86 employees.

  • What is Ra Medical Systems revenue?

    Latest Ra Medical Systems annual revenue is $4.4 m.

  • What is Ra Medical Systems revenue per employee?

    Latest Ra Medical Systems revenue per employee is $51.2 k.

  • Who are Ra Medical Systems competitors?

    Competitors of Ra Medical Systems include STRATA Skin Sciences, National Biological and Becton Dickinson.

  • Where is Ra Medical Systems headquarters?

    Ra Medical Systems headquarters is located at 2070 Las Palmas Dr, Carlsbad.

  • Where are Ra Medical Systems offices?

    Ra Medical Systems has an office in Carlsbad.

  • How many offices does Ra Medical Systems have?

    Ra Medical Systems has 1 office.